Mu-ming Poo is currently working on higher cognitive functions and models of brain disorders in China, where he's spearheaded the China Brain Project. In an interview with Neuron, he discusses the ethics of using non-human primates for research and enthuses about the potential for collaboration between AI and neuroscience researchers.
Mu-ming Poo is currently the director of the Institute of Neuroscience of Chinese Academy of Sciences (CAS) in Shanghai and director of CAS Center for Excellence in Brain Science and Intelligence Technology. He was born in Nanjing, China, grew up in Taiwan, and received a bachelor's degree in physics before moving to the United States for graduate studies in biophysics at Johns Hopkins University. He later served on the faculty of UC Irvine, Yale, Columbia, UCSD, and Berkeley, where he now holds the position of Paul Licht Distinguished Professor in Biology Emeritus. Poo has made seminal contributions in studying axon guidance, synapse formation, and plasticity, and was honored by the Gruber Neuroscience Prize in 2016. His current research focus is to use non-human primates as animal models for studying higher cognitive functions. He is a member of Academia Sinica, US National Academy of Sciences, Chinese Academy of Sciences, and Academy of Science of Hong Kong. He is also the Executive Editor-in-Chief of National Science Review.
What future direction in neuroscience are you most excited about? I am most interested in using nonhuman primates for studying higher cognitive functions that are unique to primates, and in developing non-human primate models of brain disorders, using geneediting and cloning approaches. In Shanghai, we are now building an International Center for Primate Brain Research, with facilities and practices that meet the highest international standards, so that investigators around the world can come to Shanghai to collaborate or use the facilities to pursue their own research interests. There is a long tradition of primate neurobiology that needs to be preserved and the new generation of neurobiologists should have the opportunity to work in the area. There is also a critical need to have non-human primate models for preclinical development of pharmaceutical and physiological therapies for brain disorders.
How would you like to see neuroscience evolve over the next 30 years? Along the line that I am most excited about, I would like to see neuroscience begin to extensively address the questions concerning the evolution of brain functions, e.g., the processes that drove the evolution of the primate brain, and the mechanisms by which primate-unique cognitive functions emerged. Over the past 30 years, neuroscientists have made tremendous progress in understanding the structure and function of the brain using various model organisms, focusing mainly on conserved mechanisms. For the next 30 years, I would like to see more attention paid to the diversification rather than conservation of brain functions in different species. It is great to know rodents have some innate behaviors that may be conserved in primates, but it seems equally important to know how cortical control of innate behaviors emerged in primates when substantially larger cortices had evolved.
What is your guiding philosophy for running your lab? I encourage my students and postdocs to pursue a line of research of their own interest, as long as my lab can provide the supporting facilities and expertise. This is one of the reasons my laboratory has worked in diverse fields, and many people who have left my laboratory continued the work they began in my lab. This approach is fun for me, and I have learned (perhaps rather superficially) many subjects in neuroscience by working with them, but it was perhaps more fruitful in my earlier career, when I had more time to interact with the lab members. Although I do not dictate what lab members do, I pay much attention to the work ethic in the lab. At one time some 17 years ago, disturbed by the lack of progress in the lab and frequent absence of some people, I wrote a private e-mail to my lab members, suggesting that they should spend sufficient time at the bench (put in at least 8 hr a day and 6 days a week in the lab) and inform me if they are absent from the lab for a substantial duration. I thought continuous concentration in lab work was needed for young investigators to achieve significant progress. This e-mail was later widely circulated on
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Institute of Neuroscience of Chinese Academy of Sciences (CAS) and CAS Center for Excellence in Brain Science and Intelligence Technology. the internet, and I was accused of being a ''slave-driver'' by some. Interestingly, some websites published versions of my letter that were actually modified (presumably by lab supervisors), who inserted much more strict lab rules.
Do you have a favorite anecdote from doing science that you'd like to share? When I was an assistant professor and still doing my own experiments in the lab, I was trying to find a way to measure the diffusion coefficient of acetylcholine receptors (AChRs) in their native state in the embryonic muscle membrane. The standard photobleaching method would not work because it requires a bulky fluorescent ligand attached to the receptor that inevitably impedes its diffusion rate. Knowing the precise diffusion rate is crucial for testing the hypothesis of diffusion-mediated trapping for the induction of receptor clusters by nerve terminals. It was a period of intense concentration on lab work for me. During one sleepless night lying on the bed, a simple electrophysiological solution suddenly came to my mind. The next morning, I went to the lab and did the experiment, and it worked beautifully. Within a few weeks, I collected enough data to show that the diffusion of native AChRs is rapid enough to account for the formation of receptor clusters by diffusion-mediated trapping, and published a single-author paper in Nature (1982) a few months later. Unfortunately, never again in my life has a sleepless night yielded such useful scientific thoughts.
What has been the highlight of your career? For about six years (1992) (1993) (1994) (1995) (1996) (1997) (1998) ), first at Columbia, then at UCSD, I was fortunate to have a group of very talented students and postdocs in the lab. We made most of the important discoveries of my entire career-synaptic potentiation effect of neurotrophins (with Ann Lohof), the role of spike timing in modifying synaptic efficacy of neuromuscular junctions (with Yang Dan), the role of cytoplasmic cyclic nucleotides in deciding growth cone turning responses toward guidance molecules (with Guoli Ming and Hongjun Song), the back-propagation of longterm potentiation (LTP) and long-term depression (LTD) within the neural network (with Reiko Fitzsimonds and Huizhong Tao), and the time window for spike timing-dependent plasticity (with Li Zhang, Huizhong Tao, and Guoqiang Bi). Incidentally, none of these discoveries were based on experiments proposed in my NIH grant applications.
Who were your key early influences? My student years with a brilliant biophysicist, Richard Cone, at John Hopkins University, although relatively short, had great influence in shaping the style of my later research-to ask important questions and to find simple experimental approaches (tools) to answer them. Semiquantitative simple approaches often yield insights upon which more sophisticated experimental design and analysis could later be developed. A good example was the photobleaching method for studying protein diffusion, first developed in Richard Cone's laboratory and remaining a widely used semiquantitative biophysical method for quickly demonstrating the mobility of a protein in the cell.
What's your favorite experiment? It was the experiment demonstrating the back-propagation of LTP and LTD from the output synapses to input synapses of a neuron. It was inspired by the powerful ''back-prop'' algorithm for training artificial neural networks developed in the 1980s. In the mid-1990s, when we were able to perform multiple patch recording of up to four neurons simultaneously in cultured hippocampal neurons and were in search of an interesting problem to study, it occurred to me that we could test whether synaptic modifications at the output of a neuron could influence the efficacy of the input. We found that, indeed, after LTP or LTD was induced between two cultured neurons, there was a rapid spread of LTP and LTD (within tens of minutes) to other output synapses made by and input synapses received by the presynaptic neuron. This remarkable phenomenon was later confirmed in vivo by Julin Du during his postdoctoral study in my lab-by demonstrating that LTP and LTD induced at retinotectal synapses could spread backward via the optic nerve to the bipolar cell synapses onto retinal ganglion cells. The physiological implication of this phenomenon remains to be appreciated. Nevertheless, I consider this to be the most novel discovery made by my lab. Interestingly, the papers describing this phenomenon were among the least cited of all my publications.
What is your view on big data-gathering collaborations as opposed to hypothesis-driven research by small groups? Hypothesis-driven research may also need big data gathering and analysis that require the collaborative efforts of many scientists, as exemplified by the discovery of gravitational waves. In the past century, many breakthroughs in neuroscience were made by small laboratories doing innovative work, and this will certainly continue. However, given the complexity of the brain (the ''inner universe''), the demands for big data gathering and development of new technology require large team work.
What do you think are the biggest problems/challenges science as a whole is facing today? The biggest challenge is to show the public that scientific research can meet urgent societal crisis-environmental deterioration, energy crisis, and chronic brain diseases, to name just a few. There is no question that a basic understanding of the brain will eventually help to cure brain diseases, but neuroscience cannot continue to thrive based on remote promises. We need to develop early diagnostic and intervention approaches for affective disorders and neurodegenerative diseases, even before we can really figure out their pathogenic mechanisms. Without effective solutions within the next few decades, the medical care system will collapse, and along with it the societal support for neuroscience.
What is your view of the role of science/neuroscience for society? As I said previously, science needs to face and respond effectively to societal needs. On the other hand, there is a trend in the society to have unrealistic expectations about neuroscience and AI, fueled by science fiction writers and movies. Such unrealistic expectations could lead to societal disillusion about science and scientists when we fail to deliver, and influence the policy makers who have a superficial understanding of science. Thus, we should be more involved in public dissemination of the current status of neuroscience and AI.
In your opinion, what are the most pressing questions for the field? Are there tools to tackle them? There are many related pressing questions: What is the meaning of restingstate activities in the brain? How could various cognitive functions be achieved by timely spiking activities in specific neural circuits? Why does a simple thought need to involve an extremely large population of neurons? To tackle all these questions, we need to develop tools to access the neural circuit structure and associated activities at the mesoscopic level (with cell-type specificity). The pressing question for the field thus becomes how to develop these mesoscopic tools.
How do you view the level of crosstalk between disciplines?
There are already quite a lot of crosstalks between neurobiology and other disciplines, e.g., engineering, computer and information science, chemistry, and physics. The current crosstalks need to be extended from merely technical to conceptual. For example, new conceptual advances in information science, including machine learning in AI, may impact our understanding of network structure and function of the brain. Conversely, as has happened in past decades, concepts in neuroscience could inspire the development of neural network architecture and machine learning algorithms for AI. In the CAS Center for Brain Science and Intelligence Technology, consisting of more than 100 laboratories across China, we are actively trying to promote interactions between neuroscientists and people interested in brain-inspired machine learning and computing devices. I have been giving a series of lectures on ''Neuroscience for AI,'' enthusiastically attended by AI people.
Where do you see the strongest potential for progress and new breakthroughs in neuroscience? Development of new technologies for probing the mesoscopic structure and activity of the brain, through interdisciplinary collaboration. Breakthroughs in neurotechnology will immediately lead to breakthroughs in our understanding of the brain. In Asia, where studies of non-human primates have become increasingly active, I think we will have breakthroughs in understanding higher cognitive functions and in developing effective diagnostic and therapeutic approaches for treating brain disorders, through the use of non-human primate models.
Your institute has recently succeeded in cloning macaque monkeys by somatic cell nuclear transfer (SCNT). Why did you do this? We established a non-human primate facility in my institute nine years ago because I felt that non-human primate research is indispensable for both basic and translational neuroscience, and research in this area is unfortunately declining in the West. To be useful as animal models, it would be better to have monkeys that have uniform genetic backgrounds, similar to mouse lines that are widely used. Thus, I decided to devote some of our efforts in the monkey facility to pursue cloning of macaque monkeys, using SCNT of cultured fibroblasts. Our demonstration earlier this year that monkey cloning is feasible represents only the first step. The next step is to generate gene-edited monkey clones of sufficient numbers, both for disease models and for neurobiological research, e.g., cell-type-specific tracing of mesoscopic connectome and monitoring or manipulating specific neural circuit activities.
Isn't there ethical concern in your work on non-human primates and in cloning monkeys? In terms of animal care, we have strictly followed international protocols and guidelines. The facilities we are currently constructing at the International Center for Primate Brain Research in Shanghai, under the supervision of an International Advisory Committee consisting of leaders in primate biology, will have standards higher than all existing facilities in the United States and Europe. With regard to the ethical use of non-human primates, there are currently nearly 100,000 macaque monkeys used globally (the majority used in the United States) for pharmaceutical purposes. With the development of well-established lines of cloned monkeys as animal models for preclinical studies, the number of monkeys used could be dramatically reduced because of their uniform genetic backgrounds.
Do you have a role model in science? If so, who and why? I have many role models, but as a researcher, I would name Steve Kuffler. He was a scientist with broad vision and wide interests, and he nurtured and influenced a large number of neurobiologists who became leaders of our generation. His character and impact on other neurobiologists were vividly reflected in the memorial volume ''Steve,'' written collectively by his colleagues and students.
Which do you enjoy more? Being a scientist, an administrator, or an educator? These three roles are all very challenging, and I have enjoyed all of them. Over my career, I spent most of my time as a scientist and I still supervise a laboratory. I am trying to explore new areas that younger scientists may be more reluctant to enter. I spent a substantial amount of time discussing science and advising manuscript writing with colleagues and students in my institute. In the past 4 years, I have also spent countless days helping to plan the China Brain Project.
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